PivoxMarket Explorer
Live

LLY

2026Q1BMO

Eli Lilly and Company primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2026-04-30 · Fiscal end 2026-03-31 · Features as of 2026-04-29

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS6.79
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move2.7%
IV front—
P/C full—
P/C front—
Features as of2026-04-29

Run-up

Close—
Ret 5d-7.6%
Ret 10d-5.9%
Ret 20d-7.5%
Ret 30d-8.5%

Post-Earnings Data

Results & reaction

Print

Actual EPS
8.55Beat
Estimated EPS6.79
Actual revenue
19.8B
Surprise %+25.9%
Beat / missBeat
Beat streak 44
Beat streak 84

Reaction

1-day stock reaction+4.0%
Implied vs actual

Implied 2.7%Actual 5.6%

Gap reaction+5.6%
Day result+9.8%
Next-day upYes
Realized / IV2.06×

Post tape

Post 5d+4.3%
Post 10d+7.7%
Post volume8.2M
Vol ×10d2.70×
Vol ×20d2.80×
Post range5.4%